SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,108 Cr | ₹-348 Cr | ₹4.33 Cr | ₹276 Cr |
What is the latest Net Current Assets ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,108 Cr |
| Mar2025 | ₹-348 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹276 Cr |
How is Net Current Assets of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,108 Cr | Positive | |
| Mar2025 | ₹-348 Cr | Negative | |
| Mar2024 | ₹4.33 Cr | -98.43 | |
| Mar2023 | ₹276 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,080.6 Cr | 4.7% | -18.1% | 34.9% | Stock Analytics | |
| PRIME FOCUS | ₹23,189.9 Cr | 2.8% | 27.8% | 101.7% | Stock Analytics | |
| SAGILITY | ₹20,541.7 Cr | -4.6% | 5.9% | 1.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,413.2 Cr | 1.9% | -3.8% | -42.7% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,724.1 Cr | 5.3% | 4% | -11.6% | Stock Analytics | |
| INDEGENE | ₹13,019.5 Cr | 5% | 10% | 1% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 4.7% |
-18.1% |
34.9% |
| SENSEX | 1.2% |
0.4% |
-2.9% |
You may also like the below Video Courses